Finasteride Cost in Connecticut 2026

What Does Finasteride Cost in Connecticut Right Now?

Generic finasteride tablets cost approximately $12 per month at major Connecticut retail pharmacies in 2026 when a free discount card is applied at checkout. Without any card, the same prescription can ring up between $25 and $55 per month depending on the pharmacy and quantity dispensed. Merck's brand-name Propecia carries a list price near $85 per month, though very few patients pay that amount given the wide availability of generics.

Finasteride is a type II 5-alpha-reductase inhibitor that lowers dihydrotestosterone (DHT) by roughly 60 to 70 percent at the scalp and approximately 70 percent in serum at the 1 mg dose. The FDA approved the 1 mg tablet (Propecia) for male androgenetic alopecia (AGA) in 1997 and the 5 mg tablet (Proscar) for benign prostatic hyperplasia (BPH) in 1992 1. Because the drug has been off-patent for decades, the generic supply is deep and prices are competitive.

Kaufman et al. published the landmark 48-week randomized controlled trial in the Journal of the American Academy of Dermatology (N=1,553) showing that finasteride 1 mg daily significantly increased hair count versus placebo (P<0.001) and that 83 percent of men maintained or improved hair count at one year 2. That efficacy data is what drives sustained demand, and sustained demand is precisely why generic manufacturers keep prices low.

Price snapshots across five major Connecticut pharmacy chains collected in early 2026 show a range of $9 to $18 per month for a 30-tablet supply of generic 1 mg finasteride with a discount code. The 5 mg tablet prescribed for BPH is similarly priced, sometimes lower per pill because higher-dose generics often carry steeper manufacturer rebates 3.

Connecticut Medicaid Coverage for Finasteride

Connecticut Medicaid (HUSKY Health) covers finasteride for both BPH and male-pattern hair loss, but a prior authorization (PA) is required in most cases. The PA process typically asks the prescriber to document diagnosis, duration of symptoms, and that the patient meets criteria outlined in the Connecticut Medicaid preferred drug list. Approval is commonly granted within two to five business days when documentation is complete.

The Centers for Medicare and Medicaid Services publishes state drug utilization data confirming finasteride is an active covered outpatient drug in Connecticut's fee-for-service program 4. For BPH, the clinical threshold is generally a documented International Prostate Symptom Score (IPSS) of 8 or above and a prostate volume of at least 30 mL, consistent with American Urological Association guideline recommendations 5. For AGA, the PA form typically requires a clinician-confirmed diagnosis and notation that over-the-counter alternatives such as topical minoxidil have been tried or considered.

Patients enrolled in Connecticut HUSKY D (the Medicaid expansion program for adults aged 19 to 64) follow the same PA pathway. Once approved, finasteride carries a nominal copay of $3 or less per 30-day fill for most HUSKY enrollees, making it one of the most affordable prescription options available in the state for either indication.

Medicare Part D plans available in Connecticut generally cover generic finasteride on Tier 1 or Tier 2, though coverage for the AGA indication specifically can vary by plan formulary. The Medicare Plan Finder tool at CMS.gov is the authoritative source for checking individual plan details 6.

Is Compounded Finasteride Legal in Connecticut?

Compounded finasteride is legal in Connecticut when prepared by a pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. These are state-licensed, patient-specific compounding pharmacies, and Connecticut's Department of Consumer Protection licenses and inspects them 7. A valid prescription from a licensed prescriber is required before any 503A pharmacy may compound and dispense finasteride to a Connecticut patient.

503A compounded finasteride runs approximately $45 per month in Connecticut, which is higher than the $12 cash-pay generic price but lower than Merck's list price. The clinical rationale for choosing a compounded product typically involves a non-standard dose, a different delivery vehicle (for example, a topical finasteride solution for patients who want to minimize systemic DHT suppression), or combination with another active ingredient such as minoxidil in a single topical formulation.

Topical finasteride has attracted attention in the peer-reviewed literature. A 2021 study in the Journal of the American Academy of Dermatology (N=323) found that topical finasteride 0.25 percent solution applied once daily produced similar hair-count improvements to oral 1 mg finasteride at 24 weeks with measurably lower serum DHT reductions, suggesting a potentially more favorable systemic profile 8. Compounding pharmacies in Connecticut are the primary source for topical finasteride because no FDA-approved topical formulation currently exists on the commercial market.

Connecticut law does not restrict a patient's access to 503A-compounded finasteride provided the prescription originates from a practitioner with a valid Connecticut or telehealth-compliant license. The FDA does not list finasteride on its Demonstrably Difficult to Compound or Category 1/2 bulk drug substance lists, meaning no federal barrier exists to its compounding 9.

How Connecticut Insurance Plans Cover Finasteride

Most commercial insurance plans sold through Access Health CT (Connecticut's ACA marketplace) and large employer-sponsored plans include generic finasteride on their formularies. Tier placement differs: generic finasteride commonly lands on Tier 1 ($0 to $15 copay) or Tier 2 ($20 to $50 copay) depending on the plan design. The AGA indication is sometimes excluded from coverage under plans that classify it as a cosmetic condition, while BPH-indication finasteride is almost universally covered.

The FDA-approved labeling distinguishes the two approved indications clearly. Propecia (finasteride 1 mg) carries the AGA indication; Proscar (finasteride 5 mg) carries the BPH indication 10. When a plan denies finasteride for AGA as cosmetic, a prescriber can sometimes appeal by citing the ISHRS (International Society of Hair Restoration Surgery) position that AGA has measurable psychosocial morbidity and is not purely cosmetic. The American Academy of Dermatology guidelines for AGA management explicitly recommend finasteride 1 mg daily as a first-line agent based on Level I evidence 11.

Prior authorization requirements for commercial plans in Connecticut vary. Some plans require only a diagnosis code; others request documentation of previous treatment failure. Patients whose plans deny coverage for AGA should request a formulary exception or file a standard appeal, as Connecticut state insurance regulations require insurers to provide a clear appeals pathway within 30 days 12.

The HealthRX Connecticut Finasteride Cost Decision Framework helps patients identify the right payment pathway in three steps. Step one: check whether the diagnosis is BPH or AGA, because BPH coverage is broader. Step two: verify the plan formulary tier and copay using the plan's drug cost tool or pharmacy benefits manager portal. Step three: if cost still exceeds $15 per month after insurance, apply a GoodRx or SingleCare code at checkout, because in most Connecticut cases the discount-card price beats the insurance copay outright.

The Cheapest Way to Get Finasteride in Connecticut

The single most cost-effective method for most uninsured or underinsured Connecticut patients is to present a free discount card at a high-volume pharmacy. GoodRx, SingleCare, and RxSaver all negotiate rates with pharmacy benefit managers and can bring a 30-tablet supply of generic 1 mg finasteride to $9 to $14 at chains including CVS, Walgreens, Rite Aid, and Stop and Shop locations throughout the state.

Buying a 90-day supply instead of 30 days typically drops the per-tablet price an additional 10 to 20 percent because dispensing fees are amortized over more tablets. A 90-day supply of generic finasteride 1 mg with a discount code at a Connecticut pharmacy commonly falls in the $22 to $35 range in 2026.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists generic finasteride at prices that can undercut even GoodRx rates. The service requires no insurance and ships to Connecticut addresses. Patients should confirm their prescriber is willing to send the prescription to a mail-order or cost-plus type pharmacy, which most telehealth and primary care providers readily accommodate.

For patients who qualify for Connecticut Medicaid and receive approval through the PA process, the out-of-pocket cost drops to under $3 per month, making Medicaid enrollment the cheapest pathway of all for eligible adults 13.

The Merck Patient Assistance Program provides Propecia at no cost to patients who meet income thresholds, typically at or below 200 percent of the federal poverty level. Applications are submitted through the Merck Helps program and require a prescriber signature 14. The program rarely makes financial sense for patients who can access $12 generic finasteride, but it becomes relevant when a prescriber specifically indicates brand-name only on medical grounds.

Finasteride Dosing and Clinical Basics for Connecticut Patients

Finasteride is taken once daily by mouth. The 1 mg dose is standard for AGA; the 5 mg dose is standard for BPH. No dose adjustment is needed for renal impairment. Hepatic metabolism via CYP3A4 means that strong CYP3A4 inhibitors (ketoconazole, itraconazole) may modestly raise finasteride plasma levels, though clinically significant interactions are rarely reported at the 1 mg dose 15.

Efficacy for AGA builds gradually. The Kaufman et al. trial showed that men who discontinued finasteride after two years lost the gained hair within 12 months, underscoring that treatment must be continuous to maintain results 2. Patients starting finasteride in Connecticut through telehealth or in-person care should understand that six to twelve months of consistent use is required before a meaningful clinical assessment of efficacy is possible.

Sexual side effects, including decreased libido and erectile dysfunction, occur in roughly 3.8 percent of men in clinical trials compared to 2.1 percent with placebo, per the prescribing information 16. The FDA added a label update in 2012 requiring disclosure of post-finasteride syndrome reports, though causality remains a subject of active research 17. Patients with a history of depression or sexual dysfunction should discuss the risk-benefit profile with their prescriber before starting.

Finasteride reduces PSA levels by approximately 50 percent in men taking the drug for BPH or AGA. Urologists and primary care physicians should double the measured PSA value when screening for prostate cancer in men on finasteride, per American Cancer Society guidance 18. Failure to account for this effect can lead to false reassurance about PSA trends.

Women who are pregnant or may become pregnant must not handle crushed or broken finasteride tablets. The drug is classified FDA Pregnancy Category X for female use because of the risk of hypospadias in male fetuses 19. Connecticut pharmacies dispense finasteride in sealed blister packs specifically to reduce inadvertent exposure.

Getting Finasteride via Telehealth in Connecticut

Connecticut permits telehealth prescribing of finasteride without restriction. A prescriber licensed in Connecticut may conduct a synchronous audio-video visit, review the patient's history and photographs for AGA assessment, and transmit a finasteride prescription electronically to any Connecticut-licensed pharmacy or mail-order pharmacy. The Connecticut Medical Examining Board does not require an in-person physical examination before finasteride is prescribed for AGA, though individual provider protocols may differ 20.

Telehealth platforms operating in Connecticut that offer finasteride commonly charge a monthly subscription fee between $20 and $35, which may or may not include the medication cost. When the medication is billed separately at the $12 cash-pay rate, total monthly outlay including the consultation fee runs approximately $32 to $47, which is still below the compounded product price and well below the Merck brand list price.

The Drug Enforcement Administration's Ryan Haight Act requirements do not apply to finasteride because it is not a controlled substance. Prescribers therefore face no DEA-specific telemedicine barriers for this drug, unlike Schedule II to V medications. A telemedicine-specific prescriber registration is not required for finasteride in Connecticut 21.

Patients using telehealth in Connecticut should ensure the platform uses a prescriber with an active Connecticut license verifiable through the Connecticut Department of Public Health license lookup portal. A prescription from an out-of-state prescriber without Connecticut licensure is not valid at Connecticut retail pharmacies unless the prescriber has a qualifying interstate telemedicine registration.

Connecticut Discount Programs and Savings Strategies

Several structured savings pathways exist beyond GoodRx for Connecticut finasteride patients. NeedyMeds.org maintains a database of pharmaceutical manufacturer patient assistance programs and state-specific pharmaceutical assistance programs updated quarterly 22. Connecticut's own Prescription Assistance Program (ConnPACE, now folded into CHOICES for older adults) offers co-payment assistance for qualifying seniors on fixed incomes 23.

The 340B Drug Pricing Program allows eligible federally qualified health centers (FQHCs) and safety-net hospitals in Connecticut to dispense finasteride at substantially reduced acquisition costs, passing savings to uninsured or underinsured patients. Several Connecticut FQHCs, including Community Health Center Inc. (Middletown) and Fair Haven Community Health Care (New Haven), participate in 340B and may be able to dispense finasteride at or near cost 24.

Pill splitting is a practical option for patients prescribed finasteride 5 mg for AGA who want to approximate the 1 mg dose less expensively. Cutting a 5 mg tablet into five pieces is technically feasible but imprecise. The FDA does not recommend pill splitting for modified-release formulations, though finasteride is an immediate-release tablet where splitting is pharmacokinetically reasonable. Patients should discuss this approach with their prescriber, as the 5 mg dose is FDA-approved only for BPH, not AGA 25.